Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleLaboratory Studies

Contribution of Labeled Carbon Dioxide to PET Imaging of Carbon-11-Labeled Compounds

Anthony F. Shields, Michael M. Graham, Susan M. Kozawa, Laura B. Kozell, Jeanne M. Link, Erik R. Swenson, Alexander M. Spence, James B. Bassingthwaighte and Kenneth A. Krohn
Journal of Nuclear Medicine April 1992, 33 (4) 581-584;
Anthony F. Shields
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael M. Graham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan M. Kozawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura B. Kozell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeanne M. Link
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik R. Swenson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander M. Spence
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James B. Bassingthwaighte
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth A. Krohn
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading
PDF extract preview

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 33, Issue 4
April 1, 1992
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Advertising (PDF)
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Contribution of Labeled Carbon Dioxide to PET Imaging of Carbon-11-Labeled Compounds
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Contribution of Labeled Carbon Dioxide to PET Imaging of Carbon-11-Labeled Compounds
Anthony F. Shields, Michael M. Graham, Susan M. Kozawa, Laura B. Kozell, Jeanne M. Link, Erik R. Swenson, Alexander M. Spence, James B. Bassingthwaighte, Kenneth A. Krohn
Journal of Nuclear Medicine Apr 1992, 33 (4) 581-584;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Contribution of Labeled Carbon Dioxide to PET Imaging of Carbon-11-Labeled Compounds
Anthony F. Shields, Michael M. Graham, Susan M. Kozawa, Laura B. Kozell, Jeanne M. Link, Erik R. Swenson, Alexander M. Spence, James B. Bassingthwaighte, Kenneth A. Krohn
Journal of Nuclear Medicine Apr 1992, 33 (4) 581-584;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Late Imaging with [1-11C]Acetate Improves Detection of Tumor Fatty Acid Synthesis with PET
  • Analysis and Reproducibility of 3'-Deoxy-3'-[18F]Fluorothymidine Positron Emission Tomography Imaging in Patients with Non-Small Cell Lung Cancer
  • Imaging of Cell Proliferation: Status and Prospects
  • Biodistribution and Radiation Dosimetry Estimates of 1-(2'-Deoxy-2'-18F-Fluoro-1-{beta}-D-Arabinofuranosyl)-5-Bromouracil: PET Imaging Studies in Dogs
  • 2-[11C]Thymidine Positron Emission Tomography Reproducibility in Humans
  • Radiation Dose Estimates in Humans for 11C-Acetate Whole-Body PET
  • Metabolic Activation of Temozolomide Measured in Vivo Using Positron Emission Tomography
  • Assessment of Proliferation in Vivo Using 2-[11C]Thymidine Positron Emission Tomography in Advanced Intra-abdominal Malignancies
  • Validation of FLT Uptake as a Measure of Thymidine Kinase-1 Activity in A549 Carcinoma Cells
  • Preferential Labeling of Glial and Meningial Brain Tumors with [2-14C]Acetate
  • Imaging Brain Tumor Proliferative Activity with [124I]Iododeoxyuridine
  • 2-[C-11]Thymidine Imaging of Malignant Brain Tumors
  • Google Scholar

More in this TOC Section

  • Assessment of Cancer Recurrence in Residual Tumors after Fractionated Radiotherapy: A Comparison of Fluorodeoxyglucose, L-Methionine and Thymidine
  • Monitoring Gene Therapy with Herpes Simplex Virus Thymidine Kinase in Hepatoma Cells: Uptake of Specific Substrates
  • Technetium-99m Labeling and Biodistribution of Anti-TAC Disulfide-Stabilized Fv Fragment
Show more Laboratory Studies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire